Concepedia

J. Pfisterer

JP

Statistics

Publications

8

Citations

301

H-Index

8

Active since

1999

Affiliations

Medizinische Hochschule Hannover(Current)

Helios Dr. Horst Schmidt Kliniken Wiesbaden

University of Tübingen

Goethe University Frankfurt

Christian-Albrechts-Universität zu Kiel

J. Pfisterer is an author at Medizinische Hochschule Hannover specializing in gynecology oncology, oncology, and cancer therapeutics.

Top concepts

Publications per year

1999–2015

8

Publications

8

Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum–taxane based therapy—A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)☆

U WAGNER, Andreas duBois, J. Pfisterer et al. · Gynecologic Oncology · 2006 · 89 citations

, , +10

A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies

Andreas du Bois, Jens Huober, Peter Stopfer et al. · Annals of Oncology · 2009 · 61 citations · Full text

, , +7

First-Line Chemotherapy With Epirubicin, Paclitaxel, and Carboplatin for Advanced Ovarian Cancer: A Phase I/II Study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group

Andreas du Bois, HJ Lück, Thomas Bauknecht et al. · Journal of Clinical Oncology · 1999 · 42 citations

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study

Fabian Trillsch, Sven� Mahner, Eik Vettorazzi et al. · British Journal of Cancer · 2015 · 40 citations · Full text

A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC–IV (AGO-OVAR protocol OVAR-8)

Andreas du Bois, Antje Belau, Uwe Wagner et al. · Gynecologic Oncology · 2004 · 25 citations

, , +8

1–5 of 8